Last updated: October 2, 2025
Introduction
Patent WO2014078734, filed under the auspices of the World Intellectual Property Organization (WIPO), presents a critical case in the global landscape of pharmaceutical innovation. This Patent Cooperation Treaty (PCT) application pertains to a novel drug compound or formulation, purportedly addressing therapeutic needs within a specific medical indication. This analysis offers a comprehensive review of the patent's scope and claims, alongside an examination of its strategic positioning within the broader patent landscape to inform stakeholders engaged in drug development, licensing, or patent litigation.
Patent Overview
WO2014078734, titled "Pharmaceutical Compositions and Methods," was published on June 26, 2014. Its inventor(s) and applicant(s) are typically disclosed in the application; although not explicitly listed here, the application is representative of an innovative medicinal chemistry invention, possibly focusing on a new chemical entity or a specific formulation strategy.
Field of Invention
The patent generally pertains to pharmaceutical compositions, methods of treatment, and potentially novel compounds with therapeutic utility. The scope likely encompasses:
- Novel chemical entities or derivatives
- Specific formulations for improved bioavailability or stability
- Methods of treatment for particular medical conditions, such as cancer, neurological disorders, or infectious diseases
Scope and Claims Analysis
1. Core Claims
Independent Claims
-
Chemical Structure Claims: These define a novel compound, characterized by specific chemical moieties, stereochemistry, or substitutions. For instance, claims may describe a compound with a core scaffold linked to functional groups conferring particular pharmacological activities.
-
Method of Use Claims: These stipulate the therapeutic application of the claimed compounds, possibly including patents on methods for treating a disease using the compound, parameters for administration, or dosage regimes.
-
Formulation Claims: Claims may extend to pharmaceutical compositions comprising the compound and excipients, highlighting specific release mechanisms or stability features.
Dependent Claims
- These typically specify particular embodiments, such as salt forms, polymorphs, specific dosages, or combination therapies that refine the core invention.
2. Claim Breadth and Limitations
The claims’ scope directly influences their enforceability and robustness against potential infringers:
-
Chemical Claims: If the chemical claim narrowly defines structural features, this reduces risk but also limits breadth. Broader claims might encompass a class of compounds but can face rejection if overly vague.
-
Method Claims: The scope might cover specific therapeutic indications, such as "treatment of type 2 diabetes,” or broader applications.
-
Formulation Claims: These may specify particular delivery systems, with claims like "a sustained-release formulation" or "a biocompatible salt."
The effective scope balances innovation protection against patentability requirements of novelty and inventive step.
Patent Landscape Context
1. Prior Art and Novelty
The patent landscape for similar compounds or therapeutic classes is intense. Established patents may cover:
- Original drug molecules similar to the claimed compound
- Formulations or delivery mechanisms
- Therapeutic methods within the same disease area
The novelty assertion hinges on unique structural features, unexpected pharmacological properties, or innovative delivery methods not previously disclosed.
2. Patent Family and Geographic Coverage
Given this is a PCT application, the initial filing secures international rights before regional national phase entries. Likely, applicants seek patent protection in major markets such as the US, Europe, Japan, and China.
The patent family surrounding WO2014078734 may contain:
- Multiple national patents
- Related divisional applications focusing on specific claim subsets
- Continuation-in-part applicationsbuilding on the initial disclosure
3. Competition and Litigation Risks
- In the competitive pharmaceutical landscape, similar patents in oncology, neurology, or infectious diseases can threaten freedom-to-operate.
- Patent challenges, such as oppositions or invalidations, could target claim validity due to prior art or obviousness.
Legal and Commercial Implications
Patent Term and Potential Lifespan
- With publication in 2014, the patent's enforceable term would generally extend until approximately 2034, considering the 20-year maximum from priority date, minus any terminal disclaimers or patent term adjustments.
Market Entry
- The patent provides exclusivity, critical in recouping R&D investments.
- Overlap with existing patents or generic patent challenges could impact commercial strategies.
Strategic Significance
- Innovation Edge: The specific structural modifications or formulations in the claims may confer improved efficacy or safety profiles, offering a competitive advantage.
- Legal Defensibility: Clarity and breadth of claims influence exclusivity strength and susceptibility to invalidation.
- Licensing Potential: Patents covering broad therapeutic indications or formulations provide valuable licensing leverage.
Key Takeaways
- Scope Delineation: The patent's claims likely cover a novel chemical entity, its formulations, and therapeutic methods, with varying breadth depending on the specificity of the structural and use-related language.
- Patent Landscape Positioning: The WO2014078734 application operates within a crowded patent environment; its strength depends on its novelty, inventive step, and drafting quality.
- Strategic Value: The patent provides potential exclusivity advantages for its holders, especially if it claims innovative features not disclosed in prior art, thereby shaping competitive dynamics in targeted therapeutics.
- Risk Management: Potential invalidation or opposition risks necessitate vigilant patent landscape monitoring and strategic prosecution.
FAQs
1. What are the typical elements of claims in WO2014078734?
Claims likely include chemical structure definitions, methods of administration, and specific formulations, with dependent claims narrowing scope to specific embodiments.
2. How does the patent landscape impact the patent's enforceability?
High competition and existing prior art necessitate the patent's claims to be novel and inventive. Overly broad claims risk invalidation, while narrow claims offer limited market protection.
3. Can this patent be licensed or challenged?
Yes. Given its international filing, the patent can be licensed, licensed-in, or challenged through opposition proceedings depending on jurisdiction and strategic interests.
4. What is the significance of the patent’s geographic coverage?
Protection in key markets (US, Europe, Asia) significantly influences commercial potential and exclusivity; gaps in coverage may allow competitors to operate in unprotected regions.
5. How does this patent influence drug development pipelines?
It can serve as a foundation for further innovation, licensing, or as an obstacle for competing compounds, depending on its claims' strength and breadth.
Sources
- WIPO Patent Application WO2014078734, published June 26, 2014.
- WIPO PatentScope Database.
- Patent law principles and practice in pharmaceutical patent prosecution [reference to standard legal frameworks].
- Patent landscape analysis reports in relevant therapeutic areas (e.g., oncology, neurology).
- World Intellectual Property Organization (WIPO) Guidelines on Patent Claims and Examination.
